Research Use Only (RUO): All products referenced in this article are intended solely for laboratory and research purposes. They are not approved by the FDA for research use only, are not intended to diagnose, treat, cure, or supports healthy function, and should not be used to humans or animals.
Quick Summary
- The KLOW Blend (YPB.264) is a four-component research peptide combination containing GHK-Cu (50mg), KPV (10mg), BPC-157 (10mg), and TB-500 (10mg) in a single lyophilized vial. It is designed as a research tool for studying combined anti-inflammatory, tissue repair, collagen synthesis, and regenerative biology across four complementary but mechanistically non-overlapping peptide pathways simultaneously. All four components are established research-grade synthetic peptides with independent published literature bases. Research Use Only (RUO).
- Component mechanisms: GHK-Cu (glycyl-L-histidyl-L-lysine:copper; copper tripeptide) acts through TGF-β upregulation, VEGF/EGF pathway activation, and direct collagen synthesis promotion; KPV (Lys-Pro-Val; α-MSH C-terminal tripeptide) activates melanocortin receptors (MC1R/MC3R) → NF-κB suppression → anti-inflammatory; BPC-157 (Body Protection Compound-157; 15-AA stable gastric pentadecapeptide) acts through FAK-paxillin pathway, VEGF/NO signaling, and tendon growth factor upregulation; TB-500 (thymosin β4 synthetic analog; 43 AA) sequesters G-actin via LXXLL motif, promotes cell migration, and activates wound healing cascades.
- The KLOW research rationale: each component addresses a different layer of the inflammatory and tissue repair cascade. GHK-Cu targets extracellular matrix (ECM) remodeling and copper-dependent antioxidant systems. KPV targets melanocortin-mediated NF-κB inflammatory signaling. BPC-157 targets vascular and tissue repair growth factor pathways. TB-500 targets cellular migration and actin dynamics. Together, they provide simultaneous coverage of the ECM, immune, vascular, and cytoskeletal dimensions of repair biology. YPB.264. Research Use Only (RUO). Updated April 2026.
- Pricing reference: GHK-Cu 50mg (YPB.221): Premier $23.22 / Core $27.87 / MSRP $80. Download the full catalog for all blend pricing. Individual component guides: GHK-Cu | KPV | BPC-157 | TB-500.
Research Peptide Catalog
Download the Full YourPeptideBrand.com Research Catalog
60+ research-grade compounds | Batch-specific COAs | White-label wholesale pricing
All products are intended solely for Research Use Only (RUO). Not for research use only.
What Is the KLOW Blend and How Does Each Component Contribute?
GHK-Cu 50mg + KPV 10mg
BPC-157 10mg + TB-500 10mg
Quad-Pathway Anti-Inflammatory Research
The KLOW Blend name encodes its composition: KPV + Lysyl (GHK-Cu) + Overall tissue repair (BPC-157) + Wound healing (TB-500). Updated April 2026. Its research rationale is that inflammation and tissue damage operate through multiple parallel cascades simultaneously — ECM breakdown, cytokine signaling, vascular disruption, and cellular migration impairment all occurring at once. A single-compound research design that targets only one pathway provides an incomplete model of the full repair process. The KLOW Blend provides a single-vial research tool for investigating how these four mechanistically distinct peptides interact, whether they produce additive or synergistic effects on repair endpoints, and which pathways dominate across different tissue or cellular contexts.
All four components are well-characterized individual research peptides available separately in the YPB catalog. The blend is not a proprietary formulation with unique chemistry — it is a research convenience product that combines four established compounds with complementary mechanisms in a single co-lyophilized vial.